Recombinant HIV-1 envelope protein conM SOSIP.v7 gp140 vaccine (Academisch Medisch Centrum)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant HIV-1 envelope protein conM SOSIP.v7 gp140 vaccine (Academisch Medisch Centrum)
Drug Alias NameN/A
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversiteit Van Amsterdam
China Registration ClassN/A

Develop Information

Active CompaniesUniversiteit Van Amsterdam
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A